Savient's Unsecured Creditors Blast Cash-Collateral Motion
Unsecured creditors blasted Savient Pharmaceuticals Inc.'s plan to fund its stay in Chapter 11, saying its proposed cash-collateral motion provides secured bondholders with large and unnecessary payments but brings the drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article